Cipher Pharmaceuticals

192 articles with Cipher Pharmaceuticals

• Cipher Pharma Q3 2015 Conference Call

  10/21/2015

• Cipher Pharma Announces Settlement In Patent Litigation For Absorica

  10/5/2015

• Cipher Pharma Reports Financial And Operational Results For Q2 2015

  8/14/2015

• Cipher Pharma Announces Acceptance Of 510(K) Submission For Dermadexin By FDA

  8/4/2015

• Notice Of Cipher Pharma Q2 2015 Conference Call

  7/31/2015

• Cipher Pharma Announces Successful Completion Of Second Phase III For Ozenoxacin

  7/30/2015

• Cipher Pharma To Present At 2015 JMP Securities Life Sciences Conference

  6/19/2015

• Cipher Pharma To Present At BIO International Convention

  6/4/2015

• Cipher Pharma Strengthens Leadership Team With Key Executive Appointments And Announces Launch Of Vaniqa In Canada

  6/2/2015

• Cipher Pharma To Present At Jefferies and Co. 2015 Global Healthcare Conference

  5/28/2015

• Cipher Pharma Reports Voting Results From Annual And Special Meeting Of Shareholders

  5/14/2015

• Cipher Pharma Reports Financial And Operational Results For Q1 2015

  5/13/2015

• Cipher Pharma Reports Financial And Operational Results For Q1 2015

  5/13/2015

• Cipher Pharma Acquires Canadian Commercialization Rights To Vaniqa And Actikerall

  5/6/2015

• Notice Of Cipher Pharma Q1 2015 Conference Call And 2014 Annual And Special Meeting Of Shareholders

  4/29/2015

• Cipher Pharma Announces Outcome Of Markman Hearing In Patent Infringement Suit For Absorica

  4/24/2015

• Cipher Pharma To Present At 2015 Bloom Burton & Co. Healthcare Investor Conference

  4/22/2015

• Cipher Pharma Nabs INNOCTIS and Experienced U.S. Sales Force for $45 Million Cash

  4/13/2015

• Cipher Pharmaceuticals Acquires Canadian Rights To Novel Treatment For Psoriasis And Rheumatoid Arthritis

  3/23/2015

• Can-Fite BioPharma Signs Multi-Million Dollar Distribution Agreement For CF101 In Canada With Cipher Pharmaceuticals

  3/23/2015